(Q40043099)

English

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis

scientific article published on 29 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Qian W

1

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Liu J

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Tong Y

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yan S

4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yang C

5

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Yang M

6

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Liu X

7

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

29 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

361-369

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

An adenovirus mutant that replicates selectively in p53-deficient human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Is mda-7/IL-24 a "magic bullet" for cancer?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Maturation and lineage-specific expression of the coxsackie and adenovirus receptor in hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Production of matrix metalloproteinase-9 by cord blood CD34+ cells and its role in migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

In vitro canine distemper virus infection of canine lymphoid cells: a prelude to oncolytic therapy for lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Combining high selectivity of replication with fiber chimerism for effective adenoviral oncolysis of CAR-negative melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Comparison of the efficiency of transduction of leukemic cells by fiber-modified adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

BiP/GRP78 is an intracellular target for MDA-7/IL-24 induction of cancer-specific apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

21 January 2018

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

The presence of human coxsackievirus and adenovirus receptor is associated with efficient adenovirus-mediated transgene expression in human melanoma cell cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2405034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2405034

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40043099&oldid=2203337188"